Trader consensus on Polymarket assigns a 58.5% implied probability to "No" for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential travel due to any disease—by December 31, 2026, reflecting the agency's current absence of such alerts amid stable epidemiological trends. As of early April 2026, CDC reports no Level 3 notices active, with recent Level 2 precautions limited to polio in 32 countries, meningococcal disease in the Democratic Republic of the Congo, and isolated vector-borne threats like yellow fever in Venezuela; U.S. measles cases exceed 1,700 in 17 outbreaks, but global surveillance maintains a Level 1 notice emphasizing vaccination. Declining flu activity per FluView and no sustained human-to-human bird flu or mpox transmission further dampen escalation risks, though weekly CDC updates and emerging case clusters could shift odds.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$102,379 Vol.
$102,379 Vol.
$102,379 Vol.
$102,379 Vol.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Market Opened: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus on Polymarket assigns a 58.5% implied probability to "No" for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential travel due to any disease—by December 31, 2026, reflecting the agency's current absence of such alerts amid stable epidemiological trends. As of early April 2026, CDC reports no Level 3 notices active, with recent Level 2 precautions limited to polio in 32 countries, meningococcal disease in the Democratic Republic of the Congo, and isolated vector-borne threats like yellow fever in Venezuela; U.S. measles cases exceed 1,700 in 17 outbreaks, but global surveillance maintains a Level 1 notice emphasizing vaccination. Declining flu activity per FluView and no sustained human-to-human bird flu or mpox transmission further dampen escalation risks, though weekly CDC updates and emerging case clusters could shift odds.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions